Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Meda

Deal Watch October 2015

A bumper crop of deals with seven transactions of $1bn or more

- PMLiVE

Pfizer and Allergan merger faces opposition over tax

Companiesagree deal to boost Pfizer's standing as world's largest pharma company

- PMLiVE

Meda collaborates on asthma comic book

Launches new Explain Asthma volume at ACAAI annual meeting

- PMLiVE

Mylan misses Perrigo takeover deadline

Failureto take 50% stake ends near-term hopes for a bid

Pharma deals in September 2015

September saw an interesting mix of deal types and structures, disease areas and companies hitting our Deal Watch radar. Oncology deals continue to be prominent, but the month also saw...

Pharma deals in August 2015

During a busy month AstraZeneca, Sanofi and Shire were among those hitting the headlines

- PMLiVE

Mylan joins forces with Disney on allergy treatment

Builds on its 2014 deal with the firm for its EpiPen treatment

Pharma deals in July 2015

A hot summer month for industry M&A, finds Medius Deal Watch

Boehringer Ingelheim headquarters

Hikma pays $2.6bn for Boehringer’s US generics unit

Follows Teva’s $40.5bn purchase of Allgeran’s generics business earlier this week

- PMLiVE

Teva buys Allergan generics unit for $40.5bn

Will now drop its six-month pursuit of Mylan

- PMLiVE

Making savings from European drugs budgets

National programmes of cuts are the order of the day

- PMLiVE

Teva planning fresh offer for Mylan, say sources

Israeli firm has already made multiple informal bids

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links